Cannabis-Based Medicine Trial: Multiple Sclerosis Spasticity

Cannabis-Based Medicine Trial: Multiple Sclerosis Spasticity

A six-week, placebo-controlled clinical trial of an oral spray drug derived from whole cannabis plants (Sativex® — GW Pharmaceuticals, Salisbury, UK) involving 189 individuals with multiple sclerosis showed positive changes in a self-reported measurement of...
Cannabis Treatment: Autoimmune Diseases and Inflammation

Cannabis Treatment: Autoimmune Diseases and Inflammation

In a number of painful syndromes secondary to inflammatory processes (e.g. ulcerative colitis, arthritis), cannabis products may act not only as analgesics but also demonstrate anti-inflammatory potential. For example, some patients employing cannabis report a...
Cannabis Treatment: Dependency and Withdrawal

Cannabis Treatment: Dependency and Withdrawal

According to historical and modern case reports cannabis is a good remedy to combat withdrawal in dependency on benzodiazepines, opiates and alcohol. For this reason, some have referred to it as a gateway drug back. In this context, both the reduction of physical...
Cannabis Treatment: Asthma

Cannabis Treatment: Asthma

Experiments examining the anti-asthmatic effect of THC or cannabis date mainly from the 1970s, and are all acute studies. The effects of a cannabis cigarette (2% THC) or oral THC (15 mg), respectively, approximately correspond to those obtained with therapeutic doses...
Cannabis Treatment: Epilepsy

Cannabis Treatment: Epilepsy

The use in epilepsy is among its historically oldest indications of cannabis. Animal experiments provide evidence of the antiepileptic effects of some cannabinoids. The anticonvulsant activity of phenytoin and diazepam have been potentiated by THC. According to a few...